UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 234

Sortiert nach

The Adiponectin Paradox for All-Cause and Cardiovascular Mortality

Diabetes (New York, N.Y.), 2018-01, Vol.67 (1), p.12-22

2018

Volltextzugriff (PDF)

Role of GALNT2 on Insulin Sensitivity, Lipid Metabolism and Fat Homeostasis

International journal of molecular sciences, 2022-01, Vol.23 (2), p.929

2022

Volltextzugriff (PDF)

On the emerging role of GALNT2 on intermediate metabolism and adipogenesis

Acta diabetologica, 2022-09, Vol.59 (9), p.1255-1256

2022

Volltextzugriff (PDF)

Insulin receptor signaling and glucagon-like peptide 1 effects on pancreatic beta cells

PloS one, 2017-08, Vol.12 (8), p.e0181190

2017

Volltextzugriff (PDF)

GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes

Acta diabetologica, 2024, Vol.61 (8), p.1007-1013

2024

Volltextzugriff (PDF)

Correction: GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes

Acta diabetologica, 2024, Vol.61 (8), p.1015-1015

2024

Volltextzugriff (PDF)

GALNT2 as a novel modulator of adipogenesis and adipocyte insulin signaling

International Journal of Obesity, 2019-12, Vol.43 (12), p.2448-2457

2019

Volltextzugriff (PDF)

Loss-of-Function Mutations in APPL1 in Familial Diabetes Mellitus

American journal of human genetics, 2015-07, Vol.97 (1), p.177-185

2015

Volltextzugriff (PDF)

Morphological and molecular characterization of GALNT2-mediated adipogenesis

International Journal of Obesity, 2021-06, Vol.45 (6), p.1362-1366

2021

Volltextzugriff (PDF)

Association between resistin levels and all-cause and cardiovascular mortality: a new study and a systematic review and meta-analysis

PloS one, 2015-03, Vol.10 (3), p.e0120419-e0120419

2015

Volltextzugriff (PDF)

MODY patients carrying mutation in syndromic diabetes genes. An Italian single-center experience

Acta diabetologica, 2023-01, Vol.60 (1), p.131-135

2023

Volltextzugriff (PDF)

Correction to: MODY patients carrying mutation in syndromic diabetes genes. An Italian single-center experience

Acta diabetologica, 2023-03, Vol.60 (3), p.459-459

2023

Volltextzugriff (PDF)

Contribution of ONECUT1 variants to different forms of non-autoimmune diabetes mellitus in Italian patients

Acta diabetologica, 2022-08, Vol.59 (8), p.1113-1116

2022

Volltextzugriff (PDF)

Role of Actionable Genes in Pursuing a True Approach of Precision Medicine in Monogenic Diabetes

Genes, 2022-01, Vol.13 (1), p.117

2022

Volltextzugriff (PDF)

Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes

PloS one, 2013-06, Vol.8 (6), p.e64729-e64729

2013

Volltextzugriff (PDF)

All-cause mortality prediction models in type 2 diabetes: applicability in the early stage of disease

Acta diabetologica, 2021-10, Vol.58 (10), p.1425-1428

2021

Volltextzugriff (PDF)

A Haplotype at the Adiponectin Locus Is Associated With Obesity and Other Features of the Insulin Resistance Syndrome

Diabetes (New York, N.Y.), 2002-07, Vol.51 (7), p.2306-2312

2002

Volltextzugriff (PDF)

GALNT2 expression is reduced in patients with Type 2 diabetes: possible role of hyperglycemia

PloS one, 2013-07, Vol.8 (7), p.e70159-e70159

2013

Volltextzugriff (PDF)

The novel loss of function Ile354Val mutation in PPARG causes familial partial lipodystrophy

Acta diabetologica, 2020-05, Vol.57 (5), p.589-596

2020

Volltextzugriff (PDF)

Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes

Acta diabetologica, 2022-05, Vol.59 (5), p.747-750

2022

Volltextzugriff (PDF)

Moving Toward the Implementation of Precision Medicine Needs Highly Discriminatory, Validated, Inexpensive, and Easy-to-Use Prediction Models

Diabetes care, 2020-04, Vol.43 (4), p.701-703

2020

Volltextzugriff (PDF)

Serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data

Scientific reports, 2017-03, Vol.7 (1), p.61-61, Article 61

2017

Volltextzugriff (PDF)

Identification and Clinical Characterization of Adult Patients with Multigenerational Diabetes Mellitus

PloS one, 2015-08, Vol.10 (8), p.e0135855-e0135855

2015

Volltextzugriff (PDF)

Serum Adiponectin and Glomerular Filtration Rate in Patients with Type 2 Diabetes

PloS one, 2015-10, Vol.10 (10), p.e0140631-e0140631

2015

Volltextzugriff (PDF)

A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients

Cardiovascular diabetology, 2019-08, Vol.18 (1), p.102-102, Article 102

2019

Volltextzugriff (PDF)

1 – 25 von 234

Suche als RSS-Feed

Aktive Filter

PublikationsformBerichte

ThemaEtiopathogenesis. Screening. Investigations. Target Tissue Resistance

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(221)

Publikationsform

Artikel
(233)
Buchkapitel
(1)

Sprache

Englisch
(234)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Science & Technology
(163)
Life Sciences & Biomedicine
(151)
Humans
(148)
Female
(98)
Male
(93)
Endocrinology & Metabolism
(85)
Middle Aged
(83)
Diabetes
(60)
Adult
(58)
Aged
(49)
Biological And Medical Sciences
(48)
Insulin Resistance
(47)
Medical Sciences
(42)
Diabetes Mellitus
(38)
Diabetes Mellitus, Type 2 - Genetics
(36)
Medicine
(33)
Mortality
(29)
Risk Factors
(29)
Type 2 Diabetes
(27)
Polymorphism, Single Nucleotide
(26)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Adiponectin Paradox for All-Cause and Cardiovascular Mortality

Role of GALNT2 on Insulin Sensitivity, Lipid Metabolism and Fat Homeostasis

On the emerging role of GALNT2 on intermediate metabolism and adipogenesis

Insulin receptor signaling and glucagon-like peptide 1 effects on pancreatic beta cells

GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes

Correction: GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes

GALNT2 as a novel modulator of adipogenesis and adipocyte insulin signaling

Loss-of-Function Mutations in APPL1 in Familial Diabetes Mellitus

Morphological and molecular characterization of GALNT2-mediated adipogenesis

Association between resistin levels and all-cause and cardiovascular mortality: a new study and a systematic review and meta-analysis

MODY patients carrying mutation in syndromic diabetes genes. An Italian single-center experience

Correction to: MODY patients carrying mutation in syndromic diabetes genes. An Italian single-center experience

Contribution of ONECUT1 variants to different forms of non-autoimmune diabetes mellitus in Italian patients

Role of Actionable Genes in Pursuing a True Approach of Precision Medicine in Monogenic Diabetes

Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes

All-cause mortality prediction models in type 2 diabetes: applicability in the early stage of disease

A Haplotype at the Adiponectin Locus Is Associated With Obesity and Other Features of the Insulin Resistance Syndrome

GALNT2 expression is reduced in patients with Type 2 diabetes: possible role of hyperglycemia

The novel loss of function Ile354Val mutation in PPARG causes familial partial lipodystrophy

Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes

Moving Toward the Implementation of Precision Medicine Needs Highly Discriminatory, Validated, Inexpensive, and Easy-to-Use Prediction Models

Serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data

Identification and Clinical Characterization of Adult Patients with Multigenerational Diabetes Mellitus

Serum Adiponectin and Glomerular Filtration Rate in Patients with Type 2 Diabetes

A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients

Aktive Filter

Suchergebnisse filtern